Recce Pharmaceuticals Ltd (RCE) — Cash Flow-to-Debt Ratio
Recce Pharmaceuticals Ltd (RCE) has a Cash Flow-to-Debt Ratio of -0.50x as of December 2025, meaning its operating cash flow of AU$-10.23 Million could theoretically repay 0% of its total liabilities (AU$20.66 Million) in one year. See how much free cash does Recce Pharmaceuticals Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Recce Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Recce Pharmaceuticals Ltd across 12 annual periods. Also explore Recce Pharmaceuticals Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Recce Pharmaceuticals Ltd (2014–2025)
Year-by-year debt coverage analysis for Recce Pharmaceuticals Ltd. For market capitalisation and broader financial context, see how much is Recce Pharmaceuticals Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.32x | AU$-20.44 Million | AU$15.47 Million | ▼ -61.5% |
| 2024 | -0.82x | AU$-13.01 Million | AU$15.89 Million | ▲ +66.8% |
| 2023 | -2.47x | AU$-12.69 Million | AU$5.14 Million | ▲ +29.9% |
| 2022 | -3.52x | AU$-9.01 Million | AU$2.56 Million | ▲ +47.3% |
| 2021 | -6.67x | AU$-7.86 Million | AU$1.18 Million | ▼ -63.2% |
| 2020 | -4.09x | AU$-3.81 Million | AU$931.53K | ▼ -107.8% |
| 2019 | -1.97x | AU$-2.61 Million | AU$1.33 Million | ▲ +49.0% |
| 2018 | -3.86x | AU$-1.73 Million | AU$448.82K | ▼ -35.1% |
| 2017 | -2.86x | AU$-2.50 Million | AU$874.44K | ▲ +63.3% |
| 2016 | -7.77x | AU$-1.61 Million | AU$206.80K | ▼ -615.3% |
| 2015 | -1.09x | AU$-296.14K | AU$272.47K | ▼ -2038.1% |
| 2014 | 0.06x | AU$11.43K | AU$203.81K | — |